A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism

Cited by (165)

Items 101–165 of 165

  1. Omics Insights into Metabolic Stress and Resilience of Rats in Response to Short‐term Fructose Overfeeding
    Kunping Li, Min Yuan, Zhuo‐Ru He, Qi Wu, Chu‐Mei Zhang, Zhi‐Li Lei, Xianglu Rong, Zebo Huang, Jeremy E. Turnbull, Jiao Guo · 2019 · Molecular Nutrition & Food Research
  2. Deletion of the Feeding-Induced Hepatokine TSK Ameliorates the Melanocortin Obesity Syndrome
    Qiuyu Wang, Peng Zhang, Işın Çakır, Lin Mi, Roger D. Cone, Jiandie D. Lin · 2021 · Diabetes
  3. Effect of a 6-Week Carbohydrate-Reduced High-Protein Diet on Levels of FGF21 and GDF15 in People With Type 2 Diabetes
    Michael M. Richter, Mads Norvin Thomsen, Mads Juul Skytte, Sasha A. S. Kjeldsen, Amirsalar Samkani, Jan Frystyk, Faidon Magkos, Jens Juul Holst, Sten Madsbad, Thure Krarup et al. · 2024 · Journal of the Endocrine Society
  4. Suppression of hepatic ChREBP⍺-CYP2C50 axis-driven fatty acid oxidation sensitizes mice to diet-induced MASLD/MASH
    Deqiang Zhang, Yuee Zhao, Gary Zhang, Daniel S. Lank, Sarah Cooke, Sujuan Wang, Alli M. Nuotio-Antar, Xin Tong, Lei Yin · 2024 · Molecular Metabolism
  5. FGF21 as a mediator of adaptive changes in food intake and macronutrient preference in response to protein restriction
    Sora Q. Kim, Redin A. Spann, Md Shahjalal Hossain Khan, Hans‐Rudolf Berthoud, Heike Münzberg, Vance L. Albaugh, Yanlin He, David H. McDougal, Paul L. Soto, Sangho Yu et al. · 2024 · Neuropharmacology
  6. Sugar-Sweetened Beverage Consumption May Modify Associations Between Genetic Variants in the CHREBP (Carbohydrate Responsive Element Binding Protein) Locus and HDL-C (High-Density Lipoprotein Cholesterol) and Triglyceride Concentrations
    Danielle E. Haslam, Gina Marie Peloso, Mélanie Guirette, Fumiaki Imamura, Traci M. Bartz, Achilleas Pitsillides, Carol A. Wang, Ruifang Li‐Gao, Jason Westra, Niina Pitkänen et al. · 2021 · Circulation Genomic and Precision Medicine
  7. Hepato-cardiac interorgan communication controls cardiac hypertrophy via combined endocrine-autocrine FGF21 signaling
    Sobuj Mia, Georgios Siokatas, Rafailia Sidiropoulou, Matthew Hoffman, Konstantinos Fragkiadakis, Eftychia Markopoulou, Mahmoud Elesawy, Rajika Roy, Scott Blair, Yasuhide Kuwabara et al. · 2025 · Cell Reports Medicine
  8. Ethanol induction of FGF21 in the liver is dependent on histone acetylation and ligand activation of ChREBP by glycerol-3-phosphate
    Mi Cheong Cheong, Bryan Mackowiak, Hyung Bum Kim, Genaro Hernandez, Tulip Sunil Nandu, Kevin Vale, Yuan Zhang, Lauren G. Zacharias, Thomas P. Mathews, Bin Gao et al. · 2025 · Proceedings of the National Academy of Sciences
  9. Close association between lifestyle and circulating FGF21 levels: A systematic review and meta-analysis
    Zonghao Qian, Yucong Zhang, Ni Yang, Hao Nie, Zhen Lu Yang, Pengcheng Luo, Xiuxian Wei, Yuqi Guan, Yi Huang, Jinhua Yan et al. · 2022 · Frontiers in Endocrinology
  10. The role of FGF21 in the interplay between obesity and non-alcoholic fatty liver disease: a narrative review
    Cristina Elena Negroiu, Iulia Tudorașcu, Maria Cristina Beznă, Adrian Ungureanu, Sorina Octavia Honţaru, Suzana Dănoiu · 2024 · Romanian Journal of Morphology and Embryology
  11. Parsing the Potential Neuroendocrine Actions of FGF21 in Primates
    Matthew Paul Gillum · 2018 · Endocrinology
  12. ChREBP refines the hepatic response to fructose to protect the liver from injury
    Angela M. Hall, Brian N. Finck · 2017 · Journal of Clinical Investigation
  13. Plasma FGF21 concentrations are regulated by glucose independently of insulin and GLP-1 in lean, healthy humans
    Thomas P. J. Solomon, Steven Carter, Jacob M. Haus, Kristian Karstoft, Stephanie von Holstein‐Rathlou, Mette S. Nielsen, Matthew Paul Gillum · 2022 · PeerJ
  14. FGF21-protection against fructose-induced lipid accretion and oxidative stress is influenced by maternal nutrition in male progeny
    Elena Fauste, Silvia Rodrigo, Lourdes Rodríguez, Cristina Donis, Antonia Garcı́a, Coral Barbas, Juan J. Álvarez‐Millán, Maria Isabel Panadero, Paola Otero, Carlos Bocos · 2019 · Journal of Functional Foods
  15. ATF4-dependent and independent mitokine secretion from OPA1 deficient skeletal muscle in mice is sexually dimorphic
    Jennifer Streeter, Luis Persaud, Jason Gao, Deeraj Manika, Will Fairman, Luis Miguel García-Peña, Alex Marti, Chethan Manika, Shreya Gaddi, Brandon Schickling et al. · 2024 · Frontiers in Endocrinology
  16. Fructose Protects Against Acetaminophen‐Induced Hepatotoxicity Mainly by Activating the Carbohydrate‐Response Element‐Binding Protein α–Fibroblast Growth Factor 21 Axis in Mice
    Deqiang Zhang, Sujuan Wang, Erin Ospina, Omar Shabandri, Daniel S. Lank, Jephte Yao Akakpo, Zifeng Zhao, Meichan Yang, Jun Wu, Hartmut Jaeschke et al. · 2021 · Hepatology Communications
  17. Malus toringoides (Rehd.) Hughes improves glucose and lipid metabolism and liver injury in high fructose‐induced mice
    Xianghua Quan, Qie Guo, Xiangpeng Li, Liang Yu, Mengna Cui, Jing Li, Shan Huang, Jule Wang, Bin Li · 2022 · Journal of Food Biochemistry
  18. Do Sugar-Sweetened Beverages Increase Fasting FGF21 Irrespective of the Type of Added Sugar? A Secondary Exploratory Analysis of a Randomized Controlled Trial
    Bettina Geidl, Michel Hochuli, Giatgen A. Spinas, Philipp A. Gerber · 2022 · Nutrients
  19. The Regulation of Circulating Hepatokines by Fructose Ingestion in Humans
    Michael M. Richter, Peter Plomgaard · 2021 · Journal of the Endocrine Society
  20. Fructose consumption as a risk factor for metabolic syndrome and nonalcoholic fatty liver disease
    Anna F. Sheptulina, Yu.A. Golubeva, Oksana M. Drapkina · 2023 · Russian Journal of Evidence-Based Gastroenterology
  21. Role of ChREBP and SREBP-1c in gestational diabetes: two key players in glucose and lipid metabolism
    Nurgül Eroğlu, Fatma Hümeyra Yerlikaya, Duygu Eryavuz Onmaz, Mehmet Cengiz Çolakoğlu · 2022 · International Journal of Diabetes in Developing Countries
  22. Induction of fibroblast growth factor 21 does not require activation of the hepatic X-box binding protein 1 in mice
    Shantel Olivares, Anne S. Henkel · 2017 · Molecular Metabolism
  23. The pathogenesis of metabolic dysfunction-associated steatotic liver disease and nucleoside reverse transcriptase inhibitors (NRTIs) -based HIV-antiretroviral regimens: A comprehensive narrative review
    Marilize Horn, Nontobeko Myllet Gumede, Mlindeli Wilkinson Gamede · 2025 · Biomedicine & Pharmacotherapy
  24. Hepatocellular carcinoma induced by hepatocyte Pten deletion reduces BAT UCP-1 and thermogenic capacity in mice, despite increasing serum FGF-21 and iWAT browning
    Álbert S. Peixoto, Mayara Franzoi Moreno, Érique Castro, Luiz Augusto Perandini, Thiago Belchior, Tiago E. Oliveira, Thayna S. Vieira, Gustavo R. Gilio, Caroline Aparecida Tomazelli, Bianca Franco Leonardi et al. · 2023 · Journal of Physiology and Biochemistry
  25. Treating metabolic dysfunction‐associated steatohepatitis: The fat‐trimming FGF21 approach
    Xiaokun Li, Zhiheng Rao, Wenhao Hu, Weiqin Lu, Yongde Luo · 2024 · Obesity Reviews
  26. A Systems Approach Dissociates Fructose-Induced Liver Triglyceride from Hypertriglyceridemia and Hyperinsulinemia in Male Mice
    Ludivine Doridot, Sarah Anissa Hannou, Sarah A. Krawczyk, Wenxin Tong, Mi-Sung Kim, Gregory Scott McElroy, Alan J. Fowler, Inna I. Astapova, Mark A. Herman · 2021 · Nutrients
  27. Effects of a two-week modified ketogenic diet on circulating lipoprotein subclasses, GDF15, and FGF21 in obese adults
    Nana Zhang, Na Liu, Guo-Xia Zhao, Juan Yan, Pinghua Zhang, Xiaomiao Li, Jie Zhou · 2025 · Journal of Translational Medicine
  28. Approaches to nutritional research using organoids; fructose treatment induces epigenetic changes in liver organoids
    Mirai Yamazaki, Hiroya Yamada, Eiji Munetsuna, Yoshitaka Ando, Genki Mizuno, Atsushi Teshigawara, Hayato Ichikawa, Yuki Nouchi, Itsuki Kageyama, Takuya Wakasugi et al. · 2024 · The Journal of Nutritional Biochemistry
  29. Hepatic Fat Content Is Associated with Fasting-Induced Fibroblast Growth Factor 21 Secretion in Mice Fed Soy Proteins
    Hirokazu Taniguchi, Nao Akiyama, Kengo Ishihara · 2019 · Journal of Nutritional Science and Vitaminology
  30. TSG attenuated NAFLD and facilitated weight loss in HFD-fed mice via activating the RUNX1/FGF21 signaling axis
    Zhenlin Huang, Shao-bo Zhang, Shangfu Xu, Xin-nan Gu, Zeqi Wu, Yue Zhang, Jian Li, Li-li Ji · 2025 · Acta Pharmacologica Sinica
  31. Fibroblast Growth Factor 21 (FGF21) creates sugar-specific taste aversion to fructose through action in the brain in mice
    Darko Stevanović, Alex J. Hebert, Bhavna N. Desai, Garima Singhal, Andrew Charles Adams, Jeffrey S. Flier, Eleftheria Maratos–Flier · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Molecular hydrogen mitigates acetaminophen-induced liver injury and enhances the effects of N-acetylcysteine in diabetic mice
    Naomi Kamimura, Katsuya Iuchi, Tsutomu Igarashi, Ikuroh Ohsawa, Chikako Nito, Jitsuo Usuda, Shigeo Ohta · 2025 · The Journal of Nutritional Biochemistry
  33. Genetic predeterminants and recent advancements in steatotic liver disease: A roadmap toward precision hepatology
    Ganesh Kumar, Yash R. Shah, Abeer Shahzad, Khadija Jameel, David Guevara-Lazo, Najia Ali Khan, Dushyant Singh Dahiya, Manesh Kumar Gangwani, Rakshana Ravichandran, Ravi J. Patel et al. · 2025 · World Journal of Hepatology
  34. Role of ChREBP–PPARα–FGF21 Axis in Metabolic Dysfunction of MASLD
    Karina Mireya Palacios Girón, Z. Nazará, Montserrat Maldonado‐González, Erika Martínez‐López, Martha Patricia Sánchez-Muñoz, Carlos Alfredo Bautista-López, Ma. Soledad Aldana-Aguiñaga, José Alfredo Domínguez-Rosales, Belinda Vargas‐Guerrero, Bertha Ruiz‐Madrigal · 2025 · International Journal of Molecular Sciences
  35. Pinocembrin in Indian lychee honey destabilizes hepatic lncRNA NEAT1 by inhibiting ALKBH5-mediated m6A-demethylation in non-alcoholic fatty liver disease condition
    Chandrachur Ghosh, Varuna Arora, Jyoti Barman, Somsuvra Chatterjee, Saugata Hazra, Debabrata Sircar, Prabhat Kumar, Partha Roy · 2026 · Journal of Functional Foods
  36. Metabolic benefits of ketohexokinase inhibition in individuals with MASLD: a randomized placebo-controlled crossover trial
    Evi Koene, Vera B. Schrauwen‐Hinderling, Jeremy Basset‐Sagarminaga, Kim Brouwers, Yvonne M. H. Bruls, Julian Mevenkamp, Florian Haans, Gert Schaart, Esther Moonen‐Kornips, Johanna A. Jörgensen et al. · 2026 · Nature Metabolism
  37. Differential effects of acute versus chronic dietary fructose consumption on metabolic responses in FVB/N mice
    Jordan W. Strober, Sully Fernandez, Honggang Ye, Matthew Brady · 2022 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  38. Hepatic ChREBP reciprocally modulates systemic insulin sensitivity in NAFLD
    Aniket Sen, Shilpa Thakur, Priya Rawat, Kajal Jaswal, Budheswar Dehury, Prosenjit Mondal · 2025 · Journal of Biological Chemistry
  39. Fructose-induced synaptic and neuronal adaptations at neuropeptide Y/agouti-related peptide neurons
    Mikayla A. Payant, Aditi S. Sankhe, Persephone A. Miller, Sarah S. Vieira, Yasmina Dumiaty, Jenny Phy‐Lim, Zachary L. Levy, Melissa J. S. Chee · 2025 · Molecular Metabolism
  40. Transmembrane G protein-coupled receptor 5 signaling stimulates fibroblast growth factor 21 expression concomitant with up-regulation of the transcription factor nuclear receptor Nr4a1
    Genki Kiyama, Ken‐ichi Nakashima, Kazumasa Shimada, Naoko Murono, Wataru Kakihana, Hideki Imai, Makoto Inoue, Takao Hirai · 2021 · Biomedicine & Pharmacotherapy
  41. Development of an effective and rapid qPCR for identifying human ChREBPα/β isoforms in hepatic and adipose tissues
    Sandra Margarita Ramírez-Meza, Montserrat Maldonado‐González, Z. Nazará, Erika Martínez‐López, Saúl Ocampo González, Lucina Bobadilla‐Morales, José Rodrigo Torres-Baranda, Bertha Ruiz‐Madrigal · 2019 · Scandinavian Journal of Clinical and Laboratory Investigation
  42. Glucose and lipopolysaccharide differentially regulate fibroblast growth factor 21 in healthy male human volunteers – A prospective cross‐over trial
    Johannes Pohlhammer, Matthias Wolfgang Heinzl, Carmen Klammer, Roland Feldbauer, Klemens Rosenberger, Michael Resl, Thomas Wagner, Florian Obendorf, Margot Egger-Salmhofer, Benjamin Dieplinger et al. · 2022 · Journal of Cellular and Molecular Medicine
  43. Liver Fibroblast Growth Factor 21 (FGF21) is Required for the Full Anorectic Effect of the Glucagon-Like Peptide-1 Receptor Agonist Liraglutide in Male Mice fed High Carbohydrate Diets
    Thao D. V. Le, Payam A. Fathi, Amanda B. Watters, Blair J. Ellis, Nadejda Bozadjieva-Kramer, Misty B. Perez, Andrew I. Sullivan, Jesse P. Rose, Laurie L. Baggio, Jacqueline A. Koehler et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  44. Recent advances and future trends in regulating transintestinal cholesterol excretion: Potential for nano-based therapeutic strategies
    Xiaojing Wu, Suzhe Zhou, Yongjin Li · 2026 · Nano Biomedicine and Engineering
  45. Sugar Shockwaves: How the Fructose–Glucose–ChREBP Pathway Hijacks Liver Metabolism
    Alejandro Gugliucci · 2026 · Life
  46. Master role of glucose-6-phosphate in cell signaling and consequences of its deregulation in the liver and kidneys
    Fabienne Rajas, Gilles Mithieux · 2019 · Elsevier eBooks
  47. Spirulina platensis and its ingredient biopterin glucoside improved insulin sensitivity in non-alcoholic steatohepatitis model
    Yuri Fujihara, Yasumasa Kodo, Shin-ichi Miyoshi, Ritsuko Watanabe, Hiroshi Toyoda, Mitsumasa Mankura, Hideaki Kabuto, Fusako Takayama · 2021 · Journal of Clinical Biochemistry and Nutrition
  48. Fibroblast Growth Factor 21 Has a Diverse Role in Energetic and Reproductive Physiological Functions of Female Beef Cattle
    Lígia Dias Prezotto, Jessica A. Keane, Andrea S. Cupp, Jennifer F. Thorson · 2023 · Animals
  49. Fructose-induced FGF21 secretion does not activate brown adipose tissue in Japanese young men: randomized cross-over and randomized controlled trials
    Haruki Kataoka, Shinsuke Nirengi, Yuka Matsui, Hirokazu Taniguchi · 2024 · Journal of PHYSIOLOGICAL ANTHROPOLOGY
  50. The Metabolic Effects of FGF21: From Physiology to Pharmacology
    Parkyong Song · 2020 · JoLS Journal of Life Sciences
  51. Restriction of essential amino acids dictates the systemic response to dietary protein dilution
    Yann Wan Yap, Patricia M. Rusu, Andrea Y. Chan, Barbara Christianne Fam, Andreas Jungmann, Samantha M. Solon‐Biet, Christopher K. Barlow, Darren J. Creek, Cheng Huang, Ralf B. Schittenhelm et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  52. Exercise habits and ageing health : exploring the associations of FGF21 and lung microbiome in glycaemic regulation, bone health, arterial stiffness and respiratory health
    Shuen Yee Lee · 2020 · DR-NTU (Nanyang Technological University)
  53. Rôle des hépatokines dans le dialogue inter-organes en physiologie et physiopathologie
    Aude Pacheco, Catherine Postic · 2020 · Médecine des Maladies Métaboliques
  54. Dietary Fructose and Glucose: The Multifacetted Aspects of Their Metabolism and Implication for Human Health
    Luc Tappy · 2018 · MDPI eBooks
  55. Malus toringoides (Rehd.) Hughes Improves Metabolic Syndrome and Liver Injury in High-Fructose-Induced Mice
    Xiang Hua Quan, Qie Guo, Xiangpeng Li, Liang Yu, Mengna Cui, Jing Li, Shan Huang, Bin Li · 2020 · Research Square
  56. FGF21 Counteracts Alcohol Intoxication by Activating Noradrenergic Neurons
    Mihwa Choi, Marc Schneeberger, Wei Fan, Abhijit Bugde, Laurent Gautron, Kevin Vale, Yuan Zhang, Jeffrey M. Friedman, David J. Mangelsdorf, Steven A. Kliewer · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  57. The FGF metabolic axis
    Xiaokun Li · 2024 · Elsevier eBooks
  58. Nutrient Effects and Dietary Pattern Strategies in the Management of Type 2 Diabetes
    Mingyu Sun · 2025 · Theoretical and Natural Science
  59. Mondo family proteins in diabetes
    Sandeep Kumar Barodia, Maria B. Grant, Marina S. Gorbatyuk · 2026 · Frontiers in Endocrinology
  60. Excess fructose and palm oil in the diet as factors of the development of multiple organ pathology in the experiment
    Tatiana E. Bogacheva, Калачева Алла Геннадьевна, Т. Р. Гришина, Демидов Вадим Игоревич, I. Yu. Torshin · 2026 · Pharmacoinformatics and pharmaconutritiology Current trends in data analysis
  61. Inter-organ communication in physiology and pathophysiology : a role for the ChREBP-FGF21 axis?
    Thaïs Carbinatti · 2024 · theses.fr (ABES)
  62. Indian lychee honey mitigates hepatic lipotoxicity via FAM134B-mediated reticulo-mito-phagy in MASLD
    Chandrachur Ghosh, Tathagata Kundu, Tiyasa Pathak, Somsuvra Chatterjee, Prabhat Kumar, Debabrata Sircar, Partha Roy · 2026 · Journal of Agriculture and Food Research
  63. Beneficial Hepatokines in MASLD/MASH: Therapeutic Potentials and Drug Delivery Challenges
    Reeju Amatya, Kyoung Ah Min, Meong Cheol Shin · 2026 · International Journal of Molecular Sciences
  64. Fructose nutrition during pregnancy (F0) produces, via paternal line, insulin and leptin resistance in F2 male offspring and altered liver lipid metabolism through an impaired LXRα activity in F2 female descendants
    Madelín Pérez-Armas, Elena Fauste, Maria Isabel Panadero, Paola Otero, Carlos Bocos · 2026 · Journal of Agriculture and Food Research
  65. Biological functions and emerging interplay of FGF21 and GDF15 in metabolic diseases and aging
    Laura Salmón‐Gómez, Susanne Keipert, Victoria Catalán, Amaia Rodrı́guez, Sara Becerril, Gema Frühbeck, Javier Gómez‐Ambrosi · 2026 · Molecular Biomedicine